A novel algorithm shows that there is a robust network for transferring plasmids between bacteria which may be causing the rapid spread of antibiotic resistance.
Drug-resistant diseases will be responsible for ten million deaths each year by 2050, warns a report by the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance.
Regeneron Pharmaceuticals have announced that they will collaborate with the Massachusetts-based gene therapy specialist Bluebird bio in an effort to develop and commercialise novel immune cell therapies for cancer.
The government has launched a £10 million research competition to encourage the development of novel approaches to combating antimicrobial resistance and improving infection prevention and control.